Krystal Biotech EPS Basic from Extraordinaries (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

257.63 -5.04 (-1.92%) USD | NASDAQ | Feb 20, 13:21

View EPS Basic from Extraordinaries (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	--
Alkermes Plc	--
Regeneron Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--